UPDATED 08/05/2019. This trial is now completed
The PRISM trial is an important trial into a potential treatment for bleeding in early pregnancy, led by Professor Arri Coomarasamy, Director of the Tommy’s National Centre for Miscarriage Research.
When a woman has bleeding in early pregnancy her risk of miscarriage increases:
- 1 in 3 women have a miscarriage
- 2 in 3 women go on to carry the baby to full term.
This research trial looked at whether progesterone can prevent miscarriage in women with early pregnancy bleeding.
How was the trial carried out?
4153 women took part in the trial in 48 hospitals across the UK.
Of those who were pregnant and experienced vaginal bleeding, around half were given progesterone pessaries (400mg) to take twice a day, and the other half were given dummy tablets.
A pessary is a tablet that you insert into your vagina (similar to inserting a tampon). Women were asked to do this twice a day until 16 weeks of pregnancy.
What is progesterone?
Progesterone is a hormone that is produced before and during pregnancy to thicken the uterine lining (endometrium) and to help the mother’s body accept the growing baby. It is used during fertility treatment to prepare the lining of the uterus for the implantation of the embryo.
What did the results show?
The results showed that although the treatment did not reduce the rate of miscarriage for those with no previous miscarriages, there was a small reduction in miscarriage for those with 1-2 previous miscarriages and a big reduction in miscarriage for those with 3 or more previous miscarriages.
The overall live birth rate was 75% (1513/2025) in the progesterone group and 72% (1459/2013) in the placebo group. That 3% difference in live birth was not ‘statistically significant’ – meaning that the difference could have been due to chance.
However, when the results were split by the number of previous miscarriages that the participants had suffered, the analysis showed that:
- No previous miscarriages: the live birth rate was 74% (824/1111) in the progesterone group and 75% (840/1127) in the placebo group, ie no benefit
- 1-2 previous miscarriages: the live birth rate was 76% (591/777) in the progesterone group and 72% (534/738) in the placebo group, ie some benefit
- 3 or more previous miscarriages: the live birth rate was 72% (98/137) in the progesterone group and 57% (85/148) in the placebo group, ie substantial benefit
How do we know the results of PRISM are reliable?
PRISM is a randomised, double-blind, placebo-controlled trial. This is the gold standard for a research trials. It was carried out with more than 4,000 women, which is the number needed to be certain that the results are reliable.
Together, these two factors mean the results can be trusted and we can be confident in recommending progesterone for women who have early pregnancy bleeding and 1 or more previous miscarriages.
What is a randomised, double blind, placebo-controlled trial?
Randomised: A computer made the selection completely randomly on which women were given the treatment drug (progesterone) or a placebo – a dummy drug that has no active ingredients.
Double-blind: The women in the study weren’t told whether they were taking the active medicine or the placebo – and neither were their doctors.
Placebo-controlled: Half the women in the study had the active medicine and the other half (the controls) had the placebo. The medicine that they received looked exactly the same to them and their doctors, but a completely separate group kept a record of which women had progesterone and which had the placebo.
What does this mean for women who have bleeding in pregnancy
If you have bleeding in your current pregnancy and you have had 1 or more previous miscarriages, we recommend that you ask your doctor for the progesterone treatment.
As this research is new your doctor may not be aware of it yet, and to help you we have prepared this document that explains the background and research to them. Print this out and take it with you, or, if you don’t have a printer, show it to them on your phone.
If you have any type of bleeding in pregnancy you need to see your midwife of doctor. Find out more about the causes and treatment here.
High quality evidence
Professor Arri Coomarasamy said: “The role of progesterone in women with early pregnancy bleeding has been studied and debated for about 60 years. But what we lacked was high quality evidence. The largest study before ours had less than 200 participants; our study had more than 4000 participants and was of very high quality.
This meant we could be confident about our findings. The finding that women who are at risk of a miscarriage because of current pregnancy bleeding and a history of a previous miscarriage could benefit from progesterone treatment has huge implications for practice. This treatment could save thousands of babies who may have otherwise been lost to a miscarriage.”
Information for clinicians
95% Confidence interval
Previous history of miscarriage
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. If you're interested in being kept updated about our research and news from Tommy's, click here.
A BBC News investigation has found that some private baby scanning studios are misleading customers by advertising “reassurance” scans that do not diagnose serious conditions and abnormalities.
In this Q&A, we sit down and chat with with Tom Willmott, a researcher based at Tommy’s Maternal and Fetal Health Research Centre in Manchester. He gives a rare insight into a novel and exciting area of pregnancy health research, known as ‘maternal microbiology’, looking at what we can learn by studying bacteria in the mouths of mums-to-be.
A recently published article, co-authored by Professor Catherine Williamson from Tommy’s Research Centre at King’s College London, suggests that certain pregnancy complications can indicate future health issues for women.
Tommy’s has received a grant from the UK Government’s Department for Health and Social Care to support the costs of its PregnancyHub information and support services throughout the summer, due to rising demand in the wake of coronavirus.
Natalie and Sean from Warwickshire were delighted when the found out that they were expecting twins. At 25 weeks pregnant, Natalie went into premature labour. Their daughters, Daisy and Georgie, passed away soon after birth. Natalie went on to have 2 heart-breaking miscarriages before getting support from Tommy’s National Centre for Miscarriage Research. Their rainbow baby Livvie was born in 2019.
Leanne and Kieran experienced a heart-breaking missed miscarriage before the arrival of their first daughter, Rosa. Sadly, they went on to experience another miscarriage before getting referred to Tommy’s National Centre for Miscarriage Research at Birmingham Women’s Hospital. During Leanne’s next pregnancy, she was supported by the team at our recurrent miscarriage clinic. Their second healthy baby, Pearl, was born in October 2019.
In this honest and raw account of miscarriage, Lizzie reflects on her experience and the vast array of emotions she has felt since losing 2 precious babies earlier this year. She also explores the devastating impact that baby loss can have on relationships with family and friends.
After a smooth pregnancy and labour with her son, Alice and her husband Brian hoped to give Frankie a sibling but were heartbroken by the shock of a missed miscarriage. In this blog, Alice reflects on the complex feelings of grief and guilt, and the support that has helped her to cope with the loss.
Craig, 36, lives in North Wales with his fiancée Kerry and her 6-year-old son Jacob. His job as a radio presenter and station director was difficult after the loss of their baby boy Ellis, having to entertain listeners while battling grief, but he’s now using his talent for public speaking to break the silence on miscarriage by sharing their family’s story.
Priyah and Markus from North London started trying for a baby in 2018. Sadly, in the past 2 years, they have experienced 2 miscarriages. In this blog, Markus reflects on what it feels like to lose a baby from a partner’s perspective.
Nicola sadly experienced a miscarriage just before her 12-week scan. As a doctor, she was not used to being in hospital as a patient - but has been inspired to share her story by the support she received.
Jag and her husband coped with the loss of their son in very different ways. In this blog, she reflects on the grieving process and the support that has helped her to manage the pain of her ‘favourite what if’.
Lara and her husband Joseph went through 9 rounds of IVF and experienced 2 miscarriages before making the decision to stop trying to conceive. In this blog, Lara reflects on the journey she has been on to find meaning and happiness in a life without children.
Katherine Miles from Oxford had 3 miscarriages and a life-threatening ectopic pregnancy before being referred to Tommy’s National Centre for Miscarriage Research in Coventry. After taking part in the SIMPLANT trial, her second daughter Sietske was born in 2018.
Aoife and Shane from Northern Ireland reflect on the difficult and very personal decision to temporarily stop trying to conceive during the COVID-19 pandemic.
I never found out the reason for my miscarriage. Without an explanation, you start to blame yourself
In this piece, one of our supporters shares the traumatic experience of her miscarriage. She speaks of the physical and emotional pain it caused, and how difficult it is to grapple with the feelings of guilt, grief, and future uncertainty.